NCT00159211 - Abdominal Adipose Tissue Distribution in Type 2 Diabetic Patients Treated During 6 Months With Pioglitazone or Insulin | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2005

Study Completion Date

May 31, 2007

Conditions

Type 2 Diabetes

Interventions

DRUG

UMULINE NPH

UMULINE NPH at bed time with a increasing dose up to get a fasting glycemia under 1.1 g/l

DRUG

pioglitazone

30mg daily. After 2 months, if HbA1c has not decreased at least of 1%, the dosage should be increased to 45 mg daily

Trial Locations (1)

Sce de Diabétologie, hôpital de la Pitié-salpêtrière, 83bld de l'hôpital, Paris